Invention Grant
US08445488B2 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors
有权
吡咯并[2,3-b]吡啶-4-基胺和吡咯并[2,3-b]嘧啶-5-基胺作为Janus激酶抑制剂
![Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors](/docs/US/2013-05-21/US08445488B2/abs.jpg.600x600.jpg)
- Patent Title: Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors
- Patent Title (中): 吡咯并[2,3-b]吡啶-4-基胺和吡咯并[2,3-b]嘧啶-5-基胺作为Janus激酶抑制剂
-
Application No.: US13245333Application Date: 2011-09-26
-
Publication No.: US08445488B2Publication Date: 2013-05-21
- Inventor: James D. Rodgers , Haisheng Wang , Andrew P. Combs , Richard B. Sparks
- Applicant: James D. Rodgers , Haisheng Wang , Andrew P. Combs , Richard B. Sparks
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/535
- IPC: A61K31/535 ; A61K31/44 ; A01N43/42
![Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors](/abs-image/US/2013/05/21/US08445488B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides pyrrolo[2,3-b]pyridine-4-yl amines pyrrolo[2,3-b]pyrimidin-4-yl amines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases and cancer.
Public/Granted literature
- US20120014989A1 PYRROLO[2,3-b]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-b]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS Public/Granted day:2012-01-19
Information query
